Experimental therapy stopped the metastasis of breast and ovarian cancers in lab mice, pointing toward a safe and effective alternative to chemotherapy.
A team of Stanford researchers has developed a protein therapy that disrupts the process that causes cancer cells to break away from original tumor sites, travel through the bloodstream and start aggressive new growths elsewhere in the body.
This process, known as metastasis, can cause cancer to spread with deadly effect.
“The majority of patients who succumb to cancer fall prey to metastatic forms of the disease,” said Jennifer Cochran, an associate professor of bioengineering who describes a new therapeutic approach in Nature Chemical Biology.
Today doctors try to slow or stop metastasis with chemotherapy, but these treatments are unfortunately not very effective and have severe side effects.
The Stanford team seeks to stop metastasis, without side effects, by preventing two proteins – Axl and Gas6 – from interacting to initiate the spread of cancer.
Axl proteins stand like bristles on the surface of cancer cells, poised to receive biochemical signals from Gas6 proteins.
When two Gas6 proteins link with two Axls, the signals that are generated enable cancer cells to leave the original tumor site, migrate to other parts of the body and form new cancer nodules.
To stop this process Cochran used protein engineering to create a harmless version of Axl that acts like a decoy. This decoy Axl latches on to Gas6 proteins in the bloodstream and prevents them from linking with and activating the Axls present on cancer cells.
In collaboration with Professor Amato Giaccia, who leads the Radiation Biology Program in the Stanford Cancer Center, the researchers gave intravenous treatments of this bioengineered decoy protein to mice with aggressive breast and ovarian cancers.
Mice in the breast cancer treatment group had 78 percent fewer metastatic nodules than untreated mice. Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein.
“This is a very promising therapy that appears to be effective and nontoxic in preclinical experiments,” Giaccia said. “It could open up a new approach to cancer treatment.”
The Latest on: Alternative to chemotherapy
via Google News
The Latest on: Alternative to chemotherapy
- Livermore Nonprofit Sends 5K Meals To Tri-Valley Cancer Patientson December 1, 2020 at 12:24 pm
A personal chef in Livermore who is also a breast cancer survivor has made it her mission to serve nutritious meals to cancer patients.
- Culinary Angels Provides Nutritious Meals To Cancer Patientson December 1, 2020 at 11:39 am
Both McNaney and her 18-year-old daughter are survivors of breast cancer, and her mother succumbed to cancer in 2015. A personal chef in Livermore, McNaney decided to reach out to her friend in need.
- Prostate cancer treatment approved in Englandon December 1, 2020 at 10:32 am
Following its approval in Scotland two weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer.
- CAR T Cell Therapy Market is anticipated to reach over USD 2.99 Billion by 2025on December 1, 2020 at 5:13 am
Global CAR T Cell Therapy Market is anticipated to reach over USD 2.99 Billion by 2025 According to a new research published by Polaris Market Research. The CAR T therapy uses the patient's own immune ...
- COVID-19: Fall in cancer drug treatment rose quickly following 'rapid' NHS guidanceon November 30, 2020 at 8:12 am
The number of patients starting anticancer therapies dropped by more than 30 per cent in April, the month following the UK's first COVID-19 lockdown, but went above pre-pandemic levels within three ...
- St. Jude Whoville Christmas Party open to big-hearted helperson November 29, 2020 at 6:00 pm
When 18-year-old Megan Vess died with brain cancer in May she had been a patient at the St. Jude Affiliate Clinic at Niswonger Children’s Hospital for nearly half of her ...
- New plant-based gel to fast-track 'mini-organs' growth, improve cancer treatmenton November 25, 2020 at 7:21 am
Monash University researchers have created the world's first bioactive plant-based nanocellulose hydrogel to support organoid growth and help significantly reduce the costs of studies into cancer and ...
- Irving ISD denies 150 staff requests to work from home as teacher shortage worsenson November 23, 2020 at 4:37 pm
A teacher’s aide currently on oxygen support, a special education teacher on immunosuppressants and a teacher who just completed chemotherapy were among those asked to return to campus.
- Latest Business Report on Cytotoxic Drugs Market by Emerging Trends, Share, Growth Rate, Opportunities And Market Forecast To 2027on November 19, 2020 at 2:49 am
Cytotoxic drugs market is anticipated to mask a CAGR of 1.2% during the forecast period i.e. 2018-2027. Currently the global cytotoxic drugs market is observing vibrant growth on the back of ...
- I posed for Playboy while battling a fatal brain tumour, docs said I have a year to live but cannabis is keeping me hereon November 19, 2020 at 12:53 am
A PLAYBOY model who was given just a year to live has revealed how she defied her odds by self-medicating with CANNABIS. Kerri Parker, 36, from Norwich, shunned chemotherapy in favour of the ...
via Bing News